Six Months Of Herceptin Could Be As Effective As 12 Months For Some Women With HER2 Positive Breast Cancer | Latest News RSS feed WooCommerce

Six Months Of Herceptin Could Be As Effective As 12 Months For Some Women With HER2 Positive Breast Cancer - Latest News


Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new resear... read more

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects

Explore further: Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer read more

Test of Herceptin Finds Briefer Treatment Can Work, With Fewer Side Effects

A new study finds that women who have been diagnosed with early-stage HER2-positive breast cancer did just as well with six months of treatment with the drug Herceptin (trastuzumab) as did women who r... read more

Looking for another news?


Study: Shorter drug treatment OK for many breast cancer patients

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage i... read more


Breast Cancer Patients May Shorten Herceptin Regimen: Study

"HER2-positive breast cancer ... of the women took Herceptin for six months, while the other half remained on the standard 12-month regimen. Outcomes were tracked for four years. Earl's group reported ... read more

Cancer trials show one year on Roche's Herceptin is best

Analysts had said the Swiss firm, the world's biggest maker of cancer drugs, could lose up to $1.5 billion in revenue from the blockbuster medicine in the medium term if six months treatment ... early ... read more

For Some Women, Aggressive Treatment for Early Breast Cancer

A particularly fast-growing form of breast ... positive for HER2 than if they do not. None of the women in the study received Herceptin treatment. Although the data on recurrence strongly suggest that ... read more

Patients find hope in new breast cancer research: '11 years I'm cancer free'

Cancer cells fit that characteristic, but so do some rapidly dividing ... looked at whether women with HER-2 positive early-stage breast cancer could be treated with the drug Herceptin for 6 months in... read more

Shorter breast cancer treatment could hurt providers' bottom line

Herceptin costs about $70,000 for a full year of weekly infusions that treat early-stage breast cancer. Women who used it for six months ... could increase as more immunotherapy and biologics come to ... read more

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects

A phase III randomized clinical trial of 4,088 women with HER2-positive, early-stage breast cancer found that taking trastuzumab (Herceptin) for 6 months was non-inferior to the current standard of 12 ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us